New Delhi, Dec. 26 -- Dear reader, as 2025, a year of global tumult and volatility, rolls by, Mint's reporters and columnists look around the corner on what is coming in 2026-to help you know what to expect and prepare for it. Tell us what you think at feedback@livemint.com.
NEW DELHI: India is pushing to upgrade its image from the 'pharmacy of the world' to a global life sciences hub, a goal that faces critical execution risks, especially concerning quality standards and policy follow-through. The government's roadmap for 2026 mandates stringent drug quality and the scaling up of digital health, setting the stage for a five-year phase of execution.
The market size of the industry is currently $11 billion, accounting for 1.5% of the glo...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.